Keyphrases
Escherichia Coli Infections
100%
Enterohemorrhagic Escherichia Coli
100%
Lectin Complement Pathway
100%
Ficolin-2
63%
Escherichia Coli Strains
36%
Immune Protection
27%
Lectin Pathway
18%
Prototypic
18%
Escherichia Coli Isolates
18%
Complement Deposition
18%
Recognition Molecule
18%
Membrane Attack Complex
18%
C5b-9
9%
Innate Immune Response
9%
Consumption-based
9%
Incubation
9%
Mannose-binding Lectin
9%
Acute Diarrhea
9%
Host Immune Response
9%
Partial Inhibition
9%
Bacterial Killing
9%
Normal Human Serum
9%
Complement Inhibitors
9%
ELISA Method
9%
Serum Lead
9%
Restricted numbers
9%
Complex Formation
9%
Flow Cytometry
9%
Host Factors
9%
Persistent Diarrhea
9%
Binder
9%
Evade
9%
Ficolin
9%
Complement Lectin Pathway
9%
Immunology and Microbiology
Enteroaggregative Escherichia Coli
100%
Complement Lectin Pathway
100%
Ficolin
72%
Escherichia coli
36%
Lectin Pathway
27%
Immunity
27%
Factor D
18%
Complement Deposition
18%
Complement Membrane Attack Complex
18%
Bactericidal Activity
18%
Complement Component C4b
18%
C3b
18%
Host Factor
9%
Complement Component C5b
9%
Complement Inhibitor
9%
Complement Component C1q
9%
Complex Formation
9%
Normal Human
9%
Mannose Binding Lectin
9%
ELISA
9%
Lead Blood Level
9%
Serum (Blood)
9%